Caligan Partners LP 13D/13G Filings for Opus Genetics, Inc. (IRD)

Caligan Partners LP 13D and 13G filings for Opus Genetics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2026-08-14
4:32 pm
Purchase		2026-06-3013GOPUS GENETICS, INC.
IRD		Caligan Partners LP6,077,084
7.300%		2,056increase
(+0.03%)		Filing
2026-05-15
10:56 am
Purchase		2026-03-3113GOPUS GENETICS, INC.
IRD		Caligan Partners LP6,075,028
8.500%		6,075,028increase
(New Position)		Filing